Top Markets
#1 Tutorial Tutorial +69.51%
#2 Official Trump Official Trump +29.79%
#3 Siacoin Siacoin +25.61%
#4 Mubarak Mubarak +22.50%
#5 Unit Pump Unit Pump +21.75%
#6 Pump.fun Pump.fun +21.75%
#7 Melania Meme Melania Meme +19.63%
#8 EXOD EXOD +18.93%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +18.54%
#10 MowCat MowCat +18.10%
Coin of the day
Tutorial Tutorial
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Kedudukan dalam Saham #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Harga Saham
$0.04959193
Disegerakkan terakhir: 2025-03-17
Modal Pasaran
$79.94M
Perubahan (1 hari)
13.49%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Abliva AB (publ) (ABLI)

Kategori

Healthcare
Hasil untuk Abliva AB (publ) (ABLI)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Abliva AB (publ), hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Abliva AB (publ) dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH